FinTrust Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

FinTrust Capital Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,235	Closed	-$40.5K	–	1274
2023 Q4	$40.5K	Hold	1,235	–	–	0.01%	544
2023 Q3	$34.4K	Hold	1,235	–	–	0.01%	541
2023 Q2	$34.9K	Hold	1,235	–	–	0.01%	512
2023 Q1	$34.9K	Hold	1,235	–	–	0.01%	511
2022 Q4	$34.9K	Hold	1,235	–	–	0.01%	510
2022 Q3	$40K	Hold	1,235	–	–	0.01%	550
2022 Q2	$45K	Hold	1,235	–	–	0.01%	547
2022 Q1	$57K	Hold	1,235	–	–	0.01%	534
2021 Q4	$76K	Sell	1,235 -93	-7%	-$6.43K	0.02%	479
2021 Q3	$99K	Hold	1,328	–	–	0.03%	417
2021 Q2	$123K	Buy	1,328 +1,235	+1,328%	+$105K	0.03%	371
2021 Q1	$8K	Hold	93	–	–	﹤0.01%	938
2020 Q4	$9K	Hold	93	–	–	﹤0.01%	857
2020 Q3	$6	Buy	+93	New	+$5.45K	﹤0.01%	919
2019 Q1	–	Sell	-2,390	Closed	-$57K	–	1250
2018 Q4	$57K	Buy	+2,390	New	+$67.3K	0.03%	354

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

FinTrust Capital Advisors's ARKG Position: Q1 2024 in Review

FinTrust Capital Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 1,235 shares — an estimated $40.5K sold.

FinTrust Capital Advisors first reported a position in ARKG in Q4 2018 and held it in 15 quarters. The position peaked at $123K in Q2 2021. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

FinTrust Capital Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
FinTrust Capital Advisors sold 1,235 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $40.5K.
FinTrust Capital Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 15 quarters.
FinTrust Capital Advisors's ARK Genomic Revolution ETF position peaked at $123K in Q2 2021.
284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on FinTrust Capital Advisors's 13F filing for Q1 2024, filed 2 May 2024.